Wegovy vs. Ozempic: Legal Claims and Key Differences

The Shared Active Ingredient: Semaglutide

Both Wegovy and Ozempic contain the same active ingredient: semaglutide. Manufactured by Novo Nordisk, these medications are GLP-1 receptor agonists that work through the same biological mechanism. The key difference is the dosage:

• Ozempic: Approved for type 2 diabetes, available in 0.25mg, 0.5mg, 1mg, and 2mg doses
• Wegovy: Approved for weight loss, available in higher doses up to 2.4mg

Because they share the same active ingredient, the injuries associated with both medications are nearly identical. However, there are important legal distinctions that affect how claims are filed.

Shared Injuries and Risks

Both Wegovy and Ozempic have been linked to:

• Gastroparesis (stomach paralysis)
• Pancreatitis (acute and chronic)
• Bowel obstruction (ileus)
• Gallbladder disease (requiring removal)
• Thyroid tumors (including medullary thyroid carcinoma)
• Kidney failure
• Severe gastrointestinal issues

Key Legal Differences

1. FDA Approval and Indications

• Ozempic was approved in 2017 for type 2 diabetes. Many patients taking Ozempic have a pre-existing condition (diabetes) that can itself cause some of the same injuries (e.g., diabetic gastroparesis).
• Wegovy was approved in 2021 for weight loss. Patients taking Wegovy may not have diabetes, which can make it easier to establish that the medication — not an underlying condition — caused the injury.

2. Causation Challenges

For Ozempic patients with diabetes, the defense often argues that the patient's diabetes caused the injury rather than the medication. This is particularly common in gastroparesis cases, as diabetic gastroparesis is a known complication of long-standing diabetes.

For Wegovy patients without diabetes, this defense is not available, potentially making causation easier to establish.

3. Dosage and Risk

Wegovy is prescribed at higher doses than Ozempic (up to 2.4mg vs. 2mg). Plaintiffs may argue that the higher dose increases the risk of severe injuries, which could affect the strength of the case and potential compensation.

4. Warning Labels

Both medications carry similar warning labels, but the specific warnings have evolved differently over time. The timing of when Novo Nordisk added specific warnings (e.g., for gastroparesis, ileus) can affect whether a plaintiff can prove the company failed to warn.

How Claims Are Consolidated

Because Wegovy and Ozempic share the same active ingredient and manufacturer, lawsuits for both medications are being consolidated into the same multi-district litigation (MDL). This means:

• Cases are handled by the same judge
• Discovery is shared across cases
• Bellwether trials may involve both Wegovy and Ozempic plaintiffs
• Settlement negotiations may cover both medications

Which Claim Is Right for You?

If you took either Wegovy or Ozempic and suffered a serious injury, you may have a valid legal claim. The specific medication you took affects:

1. Causation arguments: Whether the defense can argue an underlying condition caused your injury
2. Warning label timeline: Whether the manufacturer adequately warned about your specific injury at the time you were taking the medication
3. Damages calculation: The severity of your injury and its impact on your life

What to Do Next

Whether you took Wegovy or Ozempic, the process for filing a claim is similar:

1. Gather your medical records: Including prescriptions, diagnosis records, and treatment history
2. Document your symptoms and timeline: When you started the medication, when symptoms began, and when you were diagnosed
3. Get a free case review: We'll evaluate your case and connect you with an experienced attorney

Don't wait — the statute of limitations for your claim is running. Contact us today for a free, confidential case review.